TANFACINDTanfac Industries Ltd.
Tanfac Industries Q2 FY27 Results: Standalone Net Profit ₹19.03 Crore on Total Income of ₹234 Crore
- Earnings
- Chemicals
Reviewed byKeshav SehgalBlacklitt Research
Tanfac Industries (NSE: TANFACIND) reported total income of ₹234.29 crore and net profit of ₹19.03 crore for the quarter ended 30 Sep 2026, on a standalone basis, it said in a filing on 02 Nov 2026.
Key highlights
Standalone
The company on its own, without its subsidiaries
- Total income: ₹234.29 crore, up 38.4% YoY and 24.6% QoQ
- Net profit and EPS: ₹19.03 crore, up 10.8% YoY; basic EPS ₹8.93, up 3.7% YoY
- Other income: ₹3.81 crore, against ₹0.62 crore a year earlier
- Finance costs: ₹1.68 crore, up 115.6% YoY and 73.6% QoQ
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 234.29 | 169.31 | +38.4% | 188.03 | +24.6% | |
| Revenue from operations | 230.48 | 168.69 | +36.6% | 187.18 | +23.1% |
| Other income | 3.81 | 0.62 | +518.4% | 0.85 | +347.7% |
| 19.03 | 17.18 | +10.8% | 16.85 | +12.9% | |
| Profit before tax | 24.36 | 22.67 | +7.5% | 23.75 | +2.6% |
| Finance costs | 1.68 | 0.78 | +115.6% | 0.97 | +73.6% |
| Depreciation | 5.05 | 4.05 | +24.7% | 4.70 | +7.4% |
| Tax expense | 5.33 | 5.49 | -2.8% | 6.91 | -22.8% |
| Net profit margin | 8.12% | 10.15% | -2.03 pp | 8.96% | -0.84 pp |
| EPS, basic (₹) | 8.93 | 8.61 | +3.7% | 8.41 | +6.2% |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Total income grew much faster than net profit. Income rose 38.4% from the year-earlier quarter, while net profit rose 10.8% and profit before tax rose 7.5%. Revenue from operations rose 36.6%, and other income rose from ₹0.62 crore to ₹3.81 crore.
Other income of ₹3.81 crore is 15.6% of profit before tax of ₹24.36 crore, against 2.7% a year earlier on the same basis. Tax expense of ₹5.33 crore is 21.9% of profit before tax, a lower share than the ₹6.91 crore charge in the previous quarter would suggest, and it fell 2.8% from the year-earlier quarter.
Net profit margin was 8.12%, against 10.15% a year earlier and 8.96% in the previous quarter. Depreciation rose 24.7% to ₹5.05 crore and finance costs rose to ₹1.68 crore from ₹0.78 crore, a rise the filing does not explain.
The statement shows that the figures for the previous period have been rearranged or reclassified to match the current presentation. EPS for comparative periods has been adjusted for the share subdivision from ₹10 to two shares of ₹5 each, effective 9 Mar 2026.
The Board approved a 20,000 MTPA downstream fluorinated product plant at the existing location, estimated at ₹495 crore and to be commissioned in twelve months, and the project is under implementation. The filing does not say whether the plant will be commissioned on schedule or what revenue or margin it is expected to add.
The Board recommended a final dividend of ₹4.50 per equity share of ₹10 face value for FY 2025-26. Shareholders approved it at the AGM held on 23 Sep 2026, and it has been paid.
The Statutory Auditor, Ramasamy Koteswara Rao and Co LLP, issued a limited review report with an unmodified conclusion dated 2 Nov 2026. The company operates in a single segment, chemicals in India.
Inference
Shareholders approved a QIP of up to ₹500 crore on 23 Feb 2026. As on 30 Sep 2026, ₹75.55 crore of the issue proceeds was held in fixed deposits pending utilisation.
The filing does not say what the proceeds will be used for beyond the amount held in fixed deposits, and it does not say whether the dividend changes the company's dividend policy for later periods.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
